Double-Blind, Placebo-Controlled Comparative Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain
Phase of Trial: Phase III
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Fentanyl (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors SymBio Pharmaceuticals
- 09 Feb 2018 According to a SymBio Pharmaceuticals media release, the company announced today the completion of the termination of the development of IONSYS or SyB P-1501 in Japan.
- 09 Feb 2018 Status changed from recruiting to discontinued, according to a SymBio Pharmaceuticals media release.
- 16 Jun 2016 New trial record